Nanoform Finland Oyj (FRA:4YL)

Market Cap	77.53M -7.3%
Revenue (ttm)	5.42M +37.7%
Net Income	-15.97M
EPS	-0.19
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.8960
Previous Close	0.8580
Day's Range	0.8960 - 0.8960
52-Week Range	0.4135 - 1.2680
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 19, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predic...

• Industry: Commercial Physical and Biological Research
• Founded: 2008
• Employees: 171
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4YL

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.